Table 1

Study demographics

Extremely preterm
(≤27+6)
Very preterm
(28+0–32+0)
Term
(≥37+0)
Infant characteristics
 Number of participants*164245
 Birth gestation (weeks)26.4 (25.2–27.2)30.8 (29.5–31.3)40.1 (39.2–41.0)
 Male, n (%)12 (75)28 (67)21 (47)
 Female, n (%)4 (25)14 (33)24 (53)
 Birth weight (g)909±2191436±3883556±437
 Birthweight z-score†0.3±0.7−0.2±1.30.5±1
 Singleton, n (%)12 (75)30 (71)45 (100)
 Twin, n (%)4 (25)12 (29)0 (0)
Sampling characteristics
 Chronological age at diurnal samples (weeks)19.9 (17.3–23.5)18.4 (16.9–21.1)17.1 (16.3–18.9)
 Corrected age at diurnal samples (weeks)5.4 (4.0–8.9)8.9 (7.9–11.2)
 Chronological age at vaccine (weeks)20 (16.8–25.6)18.8 (17.3–20.8)17.1 (16.4–18.7)
 Corrected age at vaccine (weeks)5.6 (3.7–11.8)9.0 (8.1–11.8)
 Time of day at morning sample08:45 (08:08–09:48)08:42 (08:06–09:20)08:23 (07:50–09:05)
 Time of day at evening sample20:15 (19:40–21:11)20:19 (19:46–21:19)19:52 (19:34–20:30)
 Time of day at vaccine11:37 (11:14–13:35)11:31 (10:34–13:36)11:03 (10:05–13:21)
  • Continuous data are presented as mean±SD if normally distributed and median (IQR) if skewed.

  • *Data were unavailable for 2 participants around vaccination and 13 for diurnal assessments due to missed or insufficient volume collections.

  • †Birthweight z-scores were calculated as per the International Fetal and Newborn Growth Consortium for the 21st Century (INTERGROWTH) standards.